Pages that link to "Q24670218"
Jump to navigation
Jump to search
The following pages link to Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases (Q24670218):
Displaying 50 items.
- Research recommendations for selected IARC-classified agents (Q23912511) (← links)
- Measurements of light at night (LAN) for a sample of female school teachers (Q23917786) (← links)
- A new approach to understanding the impact of circadian disruption on human health (Q24653855) (← links)
- Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism (Q26779025) (← links)
- Breast cancer and circadian disruption from electric lighting in the modern world (Q26823410) (← links)
- Occupational cancer in Britain. Female cancers: breast, cervix and ovary (Q26828550) (← links)
- Electric light, particularly at night, disrupts human circadian rhythmicity: is that a problem? (Q26830662) (← links)
- The new world atlas of artificial night sky brightness (Q28005461) (← links)
- A case-referent study: light at night and breast cancer risk in Georgia (Q28382853) (← links)
- Cancer incidence and mortality among underground and surface goldminers in Western Australia (Q28383174) (← links)
- Sleepiness and Safety: Where Biology Needs Technology (Q28388150) (← links)
- Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey (Q28392746) (← links)
- Effects of day-time exposure to different light intensities on light-induced melatonin suppression at night (Q28397698) (← links)
- Artificial lighting as a vector attractant and cause of disease diffusion (Q28748544) (← links)
- Interaction between circadian rhythms and stress (Q28917101) (← links)
- Circadian Rhythm Disruption in Cancer Biology (Q28972554) (← links)
- High prevalence of breast cancer in light polluted areas in urban and rural regions of South Korea: An ecologic study on the treatment prevalence of female cancers based on National Health Insurance data (Q30947207) (← links)
- Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis (Q33624824) (← links)
- Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. (Q33722863) (← links)
- Circadian light (Q33777263) (← links)
- Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature (Q34042761) (← links)
- Gastrointestinal complaints in shift-working and day-working nurses in Iran (Q34220580) (← links)
- Out of the lab and into the bathroom: evening short-term exposure to conventional light suppresses melatonin and increases alertness perception (Q34324919) (← links)
- A meta-analysis on dose-response relationship between night shift work and the risk of breast cancer. (Q34366622) (← links)
- Shift work, cancer and "white-box" epidemiology: Association and causation (Q34437714) (← links)
- Environmental Circadian Disruption Worsens Neurologic Impairment and Inhibits Hippocampal Neurogenesis in Adult Rats After Traumatic Brain Injury (Q34514562) (← links)
- Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort (Q34564079) (← links)
- Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. (Q34620711) (← links)
- Roles of sunlight and natural ventilation for controlling infection: historical and current perspectives (Q34780684) (← links)
- Global co-distribution of light at night (LAN) and cancers of prostate, colon, and lung in men. (Q34921279) (← links)
- Measurement of melatonin in body fluids: standards, protocols and procedures (Q35084056) (← links)
- Light at night and breast cancer risk: results from a population-based case-control study in Connecticut, USA. (Q35160031) (← links)
- Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night (Q35181910) (← links)
- The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling (Q35220012) (← links)
- Melatonin: an inhibitor of breast cancer (Q35689110) (← links)
- Spectral identification of lighting type and character (Q35741658) (← links)
- Intermittent Fasting and Human Metabolic Health (Q35893505) (← links)
- Circadian Modulation of 8-Oxoguanine DNA Damage Repair (Q36026621) (← links)
- Prioritizing sleep for healthy work schedules (Q36031539) (← links)
- Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore (Q36335735) (← links)
- Dim light at night increases body mass of female mice (Q36628667) (← links)
- Ecological measurements of light exposure, activity, and circadian disruption. (Q36680436) (← links)
- Animal care practices in experiments on biological rhythms and sleep: report of the Joint Task Force of the Society for Research on Biological Rhythms and the Sleep Research Society (Q37052231) (← links)
- Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women (Q37071422) (← links)
- Risk assessment model for invasive breast cancer in Hong Kong women. (Q37176019) (← links)
- Light-at-night, circadian disruption and breast cancer: assessment of existing evidence (Q37324097) (← links)
- Circulating melatonin and the risk of breast and endometrial cancer in women. (Q37328085) (← links)
- Light-mediated perturbations of circadian timing and cancer risk: a mechanistic analysis. (Q37665036) (← links)
- Shift work: coping with the biological clock (Q37668860) (← links)
- Melatonin and human mitochondrial diseases (Q37715251) (← links)